LAMEA Artificial Intelligence In Cardiology Market Size, Share & Industry Analysis Report By Component, By Application, (Diagnosis, Prediction, Drug Discovery, and Other Application). By Medical Condition (Ischemic Heart Disease /CAD, Cardiac Arrhythmias, Heart Failure, and Other Medical Condition), By Country and Growth Forecast, 2025 - 2032
Published Date : 16-Jun-2025 |
Pages: 150 |
Report Format: PDF + Excel |
COVID-19 Impact on the LAMEA Artificial Intelligence In Cardiology Market
Market Overview
The Latin America, Middle East and Africa Artificial Intelligence In Cardiology Market would witness market growth of 33.8% CAGR during the forecast period (2025-2032).
The Brazil market dominated the LAMEA Artificial Intelligence In Cardiology Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $279.4 million by 2032. The Argentina market is showcasing a CAGR of 34.8% during (2025 - 2032). Additionally, The UAE market would register a CAGR of 32.4% during (2025 - 2032).
AI’s uses in cardiology are diverse, encompassing diagnostics, treatment planning, patient monitoring, and research. In diagnostics, AI enhances the accuracy of detecting conditions like atrial fibrillation (AF), heart failure, and CAD. For example, Koninklijke Philips N.V.’s ePatch, deployed across Spain in May 2024, utilizes the AI-driven Cardiologs analytics platform to detect heart arrhythmias such as AF, improving diagnostic precision through continuous monitoring.
In treatment planning, AI supports clinicians by analyzing patient data to recommend personalized interventions. The Viz Cardio Suite, launched by Viz.ai in November 2022, integrates AI to streamline cardiovascular care by combining data to produce clinical insights, accelerating communication, and ensuring patients receive timely downstream treatments. AI also plays a pivotal role in drug discovery by analyzing biomolecular networks to identify novel therapeutic targets, reducing the time and cost of developing new cardiovascular drugs.
The LAMEA region, encompassing Latin America, the Middle East, and Africa, is increasingly becoming a focal point for the application of Artificial Intelligence (AI) in cardiology. While historically challenged by limited healthcare infrastructure and disparities in medical access, the region is now witnessing a transformative shift driven by digital health innovation and government-backed modernization initiatives. Cardiovascular diseases remain among the leading causes of mortality in LAMEA, placing substantial pressure on healthcare systems to improve diagnostic accuracy, reduce treatment delays, and manage chronic conditions more efficiently.
AI technologies, particularly in cardiology, are being embraced as critical tools to address these challenges. AI-driven solutions offer capabilities such as real-time diagnostics, predictive analytics, and remote monitoring, enabling healthcare providers to detect cardiovascular issues at earlier stages and personalize treatment strategies. The demand for such technologies has grown in tandem with the region’s rising mobile connectivity, increasing investments in health tech startups, and the emergence of digital-first healthcare ecosystems.
Key influencing factors include government initiatives to modernize healthcare systems, the need for cost-effective diagnostic tools, and the growing awareness of AI's potential in improving patient outcomes. Market trends reveal a focus on integrating AI into telemedicine platforms and developing AI-powered diagnostic imaging solutions. The competitive landscape comprises international companies like GE Healthcare and Philips, as well as regional startups developing AI applications tailored to local healthcare needs. Therefore, the LAMEA region stands at a pivotal juncture in the evolution of AI in cardiology. With a mix of structural challenges and emerging opportunities, the region is poised to benefit significantly from scalable, AI-enabled cardiovascular care solutions that promise improved patient outcomes and healthcare efficiency.
Free Valuable Insights: The Worldwide Artificial Intelligence In Cardiology Market is Projected to reach USD 18.21 Billion by 2032, at a CAGR of 32.3%
Based on Component, the market is segmented into Hardware, Software, and Services. Based on Application, the market is segmented into Diagnosis, Prediction, Drug Discovery, and Other Application. Based on Medical Condition, the market is segmented into Ischemic Heart Disease /CAD, Cardiac Arrhythmias, Heart Failure, and Other Medical Condition. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- IDOVEN S.L.
- Ultromics Ltd.
- CardiAI.Inc.
- Tempus AI, Inc.
- Koninklijke Philips N.V.
- Cleerly, Inc.
- Vista AI, Inc.
- Viz.ai, Inc.
- RSIP Vision Ltd.
- GE HealthCare Technologies, Inc.
LAMEA Artificial Intelligence In Cardiology Market Report Segmentation
By Component
- Hardware
- Software
- Services
By Application
- Diagnosis
- Prediction
- Drug Discovery
- Other Application
By Medical Condition
- Ischemic Heart Disease /CAD
- Cardiac Arrhythmias
- Heart Failure
- Other Medical Condition
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Artificial Intelligence In Cardiology Market, by Component
1.4.2 LAMEA Artificial Intelligence In Cardiology Market, by Application
1.4.3 LAMEA Artificial Intelligence In Cardiology Market, by Medical Condition
1.4.4 LAMEA Artificial Intelligence In Cardiology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2024
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2021-2025)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions : 2021, Nov – 2025, Apr) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Value Chain Analysis of Artificial Intelligence In Cardiology Market
5.1 Research & Development (R&D):
5.2 Data Acquisition & Management:
5.3 Model Development & Training:
5.4 Regulatory Approval & Certification:
5.5 Product Integration & Deployment:
5.6 Marketing & Sales:
5.7 After-Sales Support & Feedback Loop:
Chapter 6. Key Customer Criteria - Artificial Intelligence In Cardiology Market
6.1 Diagnostic Accuracy
6.2 Regulatory Compliance
6.3 Data Privacy and Security
6.4 Integration with Existing Healthcare Systems
6.5 Clinical Validation and Peer-Reviewed Evidence
6.6 Ease of Use and Interface Design
6.7 Real-Time Processing and Speed
6.8 Cost-Effectiveness and Return on Investment (ROI)
6.9 Continuous Learning and Model Updates
6.10. Vendor Support and Training Services
Chapter 7. LAMEA Artificial Intelligence In Cardiology Market by Component
7.1 LAMEA Hardware Market by Country
7.2 LAMEA Software Market by Country
7.3 LAMEA Services Market by Country
Chapter 8. LAMEA Artificial Intelligence In Cardiology Market by Application
8.1 LAMEA Diagnosis Market by Country
8.2 LAMEA Prediction Market by Country
8.3 LAMEA Drug Discovery Market by Country
8.4 LAMEA Other Application Market by Country
Chapter 9. LAMEA Artificial Intelligence In Cardiology Market by Medical Condition
9.1 LAMEA Ischemic Heart Disease /CAD Market by Country
9.2 LAMEA Cardiac Arrhythmias Market by Country
9.3 LAMEA Heart Failure Market by Country
9.4 LAMEA Other Medical Condition Market by Country
Chapter 10. LAMEA Artificial Intelligence In Cardiology Market by Country
10.1 Brazil Artificial Intelligence In Cardiology Market
10.1.1 Brazil Artificial Intelligence In Cardiology Market by Component
10.1.2 Brazil Artificial Intelligence In Cardiology Market by Application
10.1.3 Brazil Artificial Intelligence In Cardiology Market by Medical Condition
10.2 Argentina Artificial Intelligence In Cardiology Market
10.2.1 Argentina Artificial Intelligence In Cardiology Market by Component
10.2.2 Argentina Artificial Intelligence In Cardiology Market by Application
10.2.3 Argentina Artificial Intelligence In Cardiology Market by Medical Condition
10.3 UAE Artificial Intelligence In Cardiology Market
10.3.1 UAE Artificial Intelligence In Cardiology Market by Component
10.3.2 UAE Artificial Intelligence In Cardiology Market by Application
10.3.3 UAE Artificial Intelligence In Cardiology Market by Medical Condition
10.4 Saudi Arabia Artificial Intelligence In Cardiology Market
10.4.1 Saudi Arabia Artificial Intelligence In Cardiology Market by Component
10.4.2 Saudi Arabia Artificial Intelligence In Cardiology Market by Application
10.4.3 Saudi Arabia Artificial Intelligence In Cardiology Market by Medical Condition
10.5 South Africa Artificial Intelligence In Cardiology Market
10.5.1 South Africa Artificial Intelligence In Cardiology Market by Component
10.5.2 South Africa Artificial Intelligence In Cardiology Market by Application
10.5.3 South Africa Artificial Intelligence In Cardiology Market by Medical Condition
10.6 Nigeria Artificial Intelligence In Cardiology Market
10.6.1 Nigeria Artificial Intelligence In Cardiology Market by Component
10.6.2 Nigeria Artificial Intelligence In Cardiology Market by Application
10.6.3 Nigeria Artificial Intelligence In Cardiology Market by Medical Condition
10.7 Rest of LAMEA Artificial Intelligence In Cardiology Market
10.7.1 Rest of LAMEA Artificial Intelligence In Cardiology Market by Component
10.7.2 Rest of LAMEA Artificial Intelligence In Cardiology Market by Application
10.7.3 Rest of LAMEA Artificial Intelligence In Cardiology Market by Medical Condition
Chapter 11. Company Profiles
11.1 IDOVEN S.L.
11.1.1 Company Overview
11.2 Ultromics Ltd.
11.2.1 Company Overview
11.2.2 Recent strategies and developments:
11.2.2.1 Partnerships, Collaborations, and Agreements:
11.2.2.2 Product Launches and Product Expansions:
11.3 CardiAI Inc.
11.3.1 Company Overview
11.4 Tempus AI, Inc.
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Research & Development Expenses
11.4.4 Recent strategies and developments:
11.4.4.1 Product Launches and Product Expansions:
11.4.4.2 Acquisition and Mergers:
11.4.5 SWOT Analysis
11.5 Koninklijke Philips N.V.
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Product Launches and Product Expansions:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 Cleerly, Inc.
11.6.1 Company Overview
11.6.2 Recent strategies and developments:
11.6.2.1 Partnerships, Collaborations, and Agreements:
11.7 Vista AI, Inc.
11.7.1 Company Overview
11.8 Viz.ai, Inc.
11.8.1 Company Overview
11.8.2 Recent strategies and developments:
11.8.2.1 Partnerships, Collaborations, and Agreements:
11.8.2.2 Product Launches and Product Expansions:
11.9 RSIP Vision Ltd.
11.9.1 Company Overview
11.10. GE HealthCare Technologies, Inc.
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Segmental and Regional Analysis
11.10.4 Research & Development Expenses
11.10.5 Recent strategies and developments:
11.10.5.1 Product Launches and Product Expansions:
11.10.6 SWOT Analysis
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Artificial Intelligence In Cardiology Market, by Component
1.4.2 LAMEA Artificial Intelligence In Cardiology Market, by Application
1.4.3 LAMEA Artificial Intelligence In Cardiology Market, by Medical Condition
1.4.4 LAMEA Artificial Intelligence In Cardiology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2024
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2021-2025)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions : 2021, Nov – 2025, Apr) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Value Chain Analysis of Artificial Intelligence In Cardiology Market
5.1 Research & Development (R&D):
5.2 Data Acquisition & Management:
5.3 Model Development & Training:
5.4 Regulatory Approval & Certification:
5.5 Product Integration & Deployment:
5.6 Marketing & Sales:
5.7 After-Sales Support & Feedback Loop:
Chapter 6. Key Customer Criteria - Artificial Intelligence In Cardiology Market
6.1 Diagnostic Accuracy
6.2 Regulatory Compliance
6.3 Data Privacy and Security
6.4 Integration with Existing Healthcare Systems
6.5 Clinical Validation and Peer-Reviewed Evidence
6.6 Ease of Use and Interface Design
6.7 Real-Time Processing and Speed
6.8 Cost-Effectiveness and Return on Investment (ROI)
6.9 Continuous Learning and Model Updates
6.10. Vendor Support and Training Services
Chapter 7. LAMEA Artificial Intelligence In Cardiology Market by Component
7.1 LAMEA Hardware Market by Country
7.2 LAMEA Software Market by Country
7.3 LAMEA Services Market by Country
Chapter 8. LAMEA Artificial Intelligence In Cardiology Market by Application
8.1 LAMEA Diagnosis Market by Country
8.2 LAMEA Prediction Market by Country
8.3 LAMEA Drug Discovery Market by Country
8.4 LAMEA Other Application Market by Country
Chapter 9. LAMEA Artificial Intelligence In Cardiology Market by Medical Condition
9.1 LAMEA Ischemic Heart Disease /CAD Market by Country
9.2 LAMEA Cardiac Arrhythmias Market by Country
9.3 LAMEA Heart Failure Market by Country
9.4 LAMEA Other Medical Condition Market by Country
Chapter 10. LAMEA Artificial Intelligence In Cardiology Market by Country
10.1 Brazil Artificial Intelligence In Cardiology Market
10.1.1 Brazil Artificial Intelligence In Cardiology Market by Component
10.1.2 Brazil Artificial Intelligence In Cardiology Market by Application
10.1.3 Brazil Artificial Intelligence In Cardiology Market by Medical Condition
10.2 Argentina Artificial Intelligence In Cardiology Market
10.2.1 Argentina Artificial Intelligence In Cardiology Market by Component
10.2.2 Argentina Artificial Intelligence In Cardiology Market by Application
10.2.3 Argentina Artificial Intelligence In Cardiology Market by Medical Condition
10.3 UAE Artificial Intelligence In Cardiology Market
10.3.1 UAE Artificial Intelligence In Cardiology Market by Component
10.3.2 UAE Artificial Intelligence In Cardiology Market by Application
10.3.3 UAE Artificial Intelligence In Cardiology Market by Medical Condition
10.4 Saudi Arabia Artificial Intelligence In Cardiology Market
10.4.1 Saudi Arabia Artificial Intelligence In Cardiology Market by Component
10.4.2 Saudi Arabia Artificial Intelligence In Cardiology Market by Application
10.4.3 Saudi Arabia Artificial Intelligence In Cardiology Market by Medical Condition
10.5 South Africa Artificial Intelligence In Cardiology Market
10.5.1 South Africa Artificial Intelligence In Cardiology Market by Component
10.5.2 South Africa Artificial Intelligence In Cardiology Market by Application
10.5.3 South Africa Artificial Intelligence In Cardiology Market by Medical Condition
10.6 Nigeria Artificial Intelligence In Cardiology Market
10.6.1 Nigeria Artificial Intelligence In Cardiology Market by Component
10.6.2 Nigeria Artificial Intelligence In Cardiology Market by Application
10.6.3 Nigeria Artificial Intelligence In Cardiology Market by Medical Condition
10.7 Rest of LAMEA Artificial Intelligence In Cardiology Market
10.7.1 Rest of LAMEA Artificial Intelligence In Cardiology Market by Component
10.7.2 Rest of LAMEA Artificial Intelligence In Cardiology Market by Application
10.7.3 Rest of LAMEA Artificial Intelligence In Cardiology Market by Medical Condition
Chapter 11. Company Profiles
11.1 IDOVEN S.L.
11.1.1 Company Overview
11.2 Ultromics Ltd.
11.2.1 Company Overview
11.2.2 Recent strategies and developments:
11.2.2.1 Partnerships, Collaborations, and Agreements:
11.2.2.2 Product Launches and Product Expansions:
11.3 CardiAI Inc.
11.3.1 Company Overview
11.4 Tempus AI, Inc.
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Research & Development Expenses
11.4.4 Recent strategies and developments:
11.4.4.1 Product Launches and Product Expansions:
11.4.4.2 Acquisition and Mergers:
11.4.5 SWOT Analysis
11.5 Koninklijke Philips N.V.
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Product Launches and Product Expansions:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 Cleerly, Inc.
11.6.1 Company Overview
11.6.2 Recent strategies and developments:
11.6.2.1 Partnerships, Collaborations, and Agreements:
11.7 Vista AI, Inc.
11.7.1 Company Overview
11.8 Viz.ai, Inc.
11.8.1 Company Overview
11.8.2 Recent strategies and developments:
11.8.2.1 Partnerships, Collaborations, and Agreements:
11.8.2.2 Product Launches and Product Expansions:
11.9 RSIP Vision Ltd.
11.9.1 Company Overview
11.10. GE HealthCare Technologies, Inc.
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Segmental and Regional Analysis
11.10.4 Research & Development Expenses
11.10.5 Recent strategies and developments:
11.10.5.1 Product Launches and Product Expansions:
11.10.6 SWOT Analysis
List of Tables
TABLE 1 LAMEA Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 2 LAMEA Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Artificial Intelligence In Cardiology Market
TABLE 4 Product Launches And Product Expansions– Artificial Intelligence In Cardiology Market
TABLE 5 Acquisition and Mergers– Artificial Intelligence In Cardiology Market
TABLE 6 Key Customer Criteria - Artificial Intelligence In Cardiology Market
TABLE 7 LAMEA Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 8 LAMEA Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 9 LAMEA Hardware Market by Country, 2021 - 2024, USD Million
TABLE 10 LAMEA Hardware Market by Country, 2025 - 2032, USD Million
TABLE 11 LAMEA Software Market by Country, 2021 - 2024, USD Million
TABLE 12 LAMEA Software Market by Country, 2025 - 2032, USD Million
TABLE 13 LAMEA Services Market by Country, 2021 - 2024, USD Million
TABLE 14 LAMEA Services Market by Country, 2025 - 2032, USD Million
TABLE 15 LAMEA Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 16 LAMEA Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 17 LAMEA Diagnosis Market by Country, 2021 - 2024, USD Million
TABLE 18 LAMEA Diagnosis Market by Country, 2025 - 2032, USD Million
TABLE 19 LAMEA Prediction Market by Country, 2021 - 2024, USD Million
TABLE 20 LAMEA Prediction Market by Country, 2025 - 2032, USD Million
TABLE 21 LAMEA Drug Discovery Market by Country, 2021 - 2024, USD Million
TABLE 22 LAMEA Drug Discovery Market by Country, 2025 - 2032, USD Million
TABLE 23 LAMEA Other Application Market by Country, 2021 - 2024, USD Million
TABLE 24 LAMEA Other Application Market by Country, 2025 - 2032, USD Million
TABLE 25 LAMEA Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 26 LAMEA Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 27 LAMEA Ischemic Heart Disease /CAD Market by Country, 2021 - 2024, USD Million
TABLE 28 LAMEA Ischemic Heart Disease /CAD Market by Country, 2025 - 2032, USD Million
TABLE 29 LAMEA Cardiac Arrhythmias Market by Country, 2021 - 2024, USD Million
TABLE 30 LAMEA Cardiac Arrhythmias Market by Country, 2025 - 2032, USD Million
TABLE 31 LAMEA Heart Failure Market by Country, 2021 - 2024, USD Million
TABLE 32 LAMEA Heart Failure Market by Country, 2025 - 2032, USD Million
TABLE 33 LAMEA Other Medical Condition Market by Country, 2021 - 2024, USD Million
TABLE 34 LAMEA Other Medical Condition Market by Country, 2025 - 2032, USD Million
TABLE 35 LAMEA Artificial Intelligence In Cardiology Market by Country, 2021 - 2024, USD Million
TABLE 36 LAMEA Artificial Intelligence In Cardiology Market by Country, 2025 - 2032, USD Million
TABLE 37 Brazil Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 38 Brazil Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 39 Brazil Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 40 Brazil Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 41 Brazil Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 42 Brazil Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 43 Brazil Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 44 Brazil Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 45 Argentina Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 46 Argentina Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 47 Argentina Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 48 Argentina Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 49 Argentina Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 50 Argentina Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 51 Argentina Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 52 Argentina Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 53 UAE Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 54 UAE Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 55 UAE Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 56 UAE Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 57 UAE Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 58 UAE Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 59 UAE Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 60 UAE Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 61 Saudi Arabia Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 62 Saudi Arabia Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 63 Saudi Arabia Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 64 Saudi Arabia Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 65 Saudi Arabia Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 66 Saudi Arabia Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 67 Saudi Arabia Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 68 Saudi Arabia Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 69 South Africa Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 70 South Africa Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 71 South Africa Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 72 South Africa Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 73 South Africa Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 74 South Africa Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 75 South Africa Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 76 South Africa Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 77 Nigeria Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 78 Nigeria Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 79 Nigeria Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 80 Nigeria Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 81 Nigeria Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 82 Nigeria Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 83 Nigeria Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 84 Nigeria Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 85 Rest of LAMEA Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 86 Rest of LAMEA Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 87 Rest of LAMEA Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 88 Rest of LAMEA Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 89 Rest of LAMEA Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 90 Rest of LAMEA Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 91 Rest of LAMEA Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 92 Rest of LAMEA Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 93 Key Information – IDOVEN S.L.
TABLE 94 Key Information – Ultromics Ltd.
TABLE 95 Key Information – CardiAI Inc.
TABLE 96 Key Information – Tempus AI, Inc.
TABLE 97 Key Information – Koninklijke Philips N.V.
TABLE 98 Key Information – Cleerly, Inc.
TABLE 99 Key Information – Vista AI, Inc.
TABLE 100 Key Information – Viz.ai, Inc.
TABLE 101 Key Information – RSIP Vision Ltd.
TABLE 102 Key Information – GE HealthCare Technologies, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Artificial Intelligence In Cardiology Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting Artificial Intelligence In Cardiology Market
FIG 4 KBV Cardinal Matrix
FIG 5 Market Share Analysis, 2024
FIG 6 Key Leading Strategies: Percentage Distribution (2021-2025)
FIG 7 Key Strategic Move: (Product Launches and Product Expansions : 2021, Nov – 2025, Apr) Leading Players
FIG 8 Porter Five Forces Analysis - Artificial Intelligence In Cardiology Market
FIG 9 Value Chain Analysis of Artificial Intelligence In Cardiology Market
FIG 10 Key Customer Criteria - Artificial Intelligence In Cardiology Market
FIG 11 LAMEA Artificial Intelligence In Cardiology Market share by Component, 2024
FIG 12 LAMEA Artificial Intelligence In Cardiology Market share by Component, 2032
FIG 13 LAMEA Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
FIG 14 LAMEA Artificial Intelligence In Cardiology Market share by Application, 2024
FIG 15 LAMEA Artificial Intelligence In Cardiology Market share by Application, 2032
FIG 16 LAMEA Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
FIG 17 LAMEA Artificial Intelligence In Cardiology Market share by Medical Condition, 2024
FIG 18 LAMEA Artificial Intelligence In Cardiology Market share by Medical Condition, 2032
FIG 19 LAMEA Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
FIG 20 LAMEA Artificial Intelligence In Cardiology Market share by Country, 2024
FIG 21 LAMEA Artificial Intelligence In Cardiology Market share by Country, 2032
FIG 22 LAMEA Artificial Intelligence In Cardiology Market by Country, 2025 - 2032, USD Million
FIG 23 Recent strategies and developments: Ultromics Ltd.
FIG 24 Recent strategies and developments: Tempus AI, Inc.
FIG 25 SWOT Analysis: Tempus AI, Inc.
FIG 26 Recent strategies and developments: Koninklijke Philips N.V.
FIG 27 SWOT Analysis: Koninklijke Philips N.V.
FIG 28 Recent strategies and developments: Viz.ai, Inc.
FIG 29 SWOT Analysis: GE HealthCare Technologies, Inc.
TABLE 2 LAMEA Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Artificial Intelligence In Cardiology Market
TABLE 4 Product Launches And Product Expansions– Artificial Intelligence In Cardiology Market
TABLE 5 Acquisition and Mergers– Artificial Intelligence In Cardiology Market
TABLE 6 Key Customer Criteria - Artificial Intelligence In Cardiology Market
TABLE 7 LAMEA Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 8 LAMEA Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 9 LAMEA Hardware Market by Country, 2021 - 2024, USD Million
TABLE 10 LAMEA Hardware Market by Country, 2025 - 2032, USD Million
TABLE 11 LAMEA Software Market by Country, 2021 - 2024, USD Million
TABLE 12 LAMEA Software Market by Country, 2025 - 2032, USD Million
TABLE 13 LAMEA Services Market by Country, 2021 - 2024, USD Million
TABLE 14 LAMEA Services Market by Country, 2025 - 2032, USD Million
TABLE 15 LAMEA Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 16 LAMEA Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 17 LAMEA Diagnosis Market by Country, 2021 - 2024, USD Million
TABLE 18 LAMEA Diagnosis Market by Country, 2025 - 2032, USD Million
TABLE 19 LAMEA Prediction Market by Country, 2021 - 2024, USD Million
TABLE 20 LAMEA Prediction Market by Country, 2025 - 2032, USD Million
TABLE 21 LAMEA Drug Discovery Market by Country, 2021 - 2024, USD Million
TABLE 22 LAMEA Drug Discovery Market by Country, 2025 - 2032, USD Million
TABLE 23 LAMEA Other Application Market by Country, 2021 - 2024, USD Million
TABLE 24 LAMEA Other Application Market by Country, 2025 - 2032, USD Million
TABLE 25 LAMEA Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 26 LAMEA Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 27 LAMEA Ischemic Heart Disease /CAD Market by Country, 2021 - 2024, USD Million
TABLE 28 LAMEA Ischemic Heart Disease /CAD Market by Country, 2025 - 2032, USD Million
TABLE 29 LAMEA Cardiac Arrhythmias Market by Country, 2021 - 2024, USD Million
TABLE 30 LAMEA Cardiac Arrhythmias Market by Country, 2025 - 2032, USD Million
TABLE 31 LAMEA Heart Failure Market by Country, 2021 - 2024, USD Million
TABLE 32 LAMEA Heart Failure Market by Country, 2025 - 2032, USD Million
TABLE 33 LAMEA Other Medical Condition Market by Country, 2021 - 2024, USD Million
TABLE 34 LAMEA Other Medical Condition Market by Country, 2025 - 2032, USD Million
TABLE 35 LAMEA Artificial Intelligence In Cardiology Market by Country, 2021 - 2024, USD Million
TABLE 36 LAMEA Artificial Intelligence In Cardiology Market by Country, 2025 - 2032, USD Million
TABLE 37 Brazil Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 38 Brazil Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 39 Brazil Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 40 Brazil Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 41 Brazil Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 42 Brazil Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 43 Brazil Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 44 Brazil Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 45 Argentina Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 46 Argentina Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 47 Argentina Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 48 Argentina Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 49 Argentina Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 50 Argentina Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 51 Argentina Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 52 Argentina Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 53 UAE Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 54 UAE Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 55 UAE Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 56 UAE Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 57 UAE Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 58 UAE Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 59 UAE Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 60 UAE Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 61 Saudi Arabia Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 62 Saudi Arabia Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 63 Saudi Arabia Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 64 Saudi Arabia Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 65 Saudi Arabia Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 66 Saudi Arabia Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 67 Saudi Arabia Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 68 Saudi Arabia Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 69 South Africa Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 70 South Africa Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 71 South Africa Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 72 South Africa Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 73 South Africa Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 74 South Africa Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 75 South Africa Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 76 South Africa Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 77 Nigeria Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 78 Nigeria Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 79 Nigeria Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 80 Nigeria Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 81 Nigeria Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 82 Nigeria Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 83 Nigeria Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 84 Nigeria Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 85 Rest of LAMEA Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 86 Rest of LAMEA Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 87 Rest of LAMEA Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 88 Rest of LAMEA Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 89 Rest of LAMEA Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 90 Rest of LAMEA Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 91 Rest of LAMEA Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 92 Rest of LAMEA Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 93 Key Information – IDOVEN S.L.
TABLE 94 Key Information – Ultromics Ltd.
TABLE 95 Key Information – CardiAI Inc.
TABLE 96 Key Information – Tempus AI, Inc.
TABLE 97 Key Information – Koninklijke Philips N.V.
TABLE 98 Key Information – Cleerly, Inc.
TABLE 99 Key Information – Vista AI, Inc.
TABLE 100 Key Information – Viz.ai, Inc.
TABLE 101 Key Information – RSIP Vision Ltd.
TABLE 102 Key Information – GE HealthCare Technologies, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Artificial Intelligence In Cardiology Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting Artificial Intelligence In Cardiology Market
FIG 4 KBV Cardinal Matrix
FIG 5 Market Share Analysis, 2024
FIG 6 Key Leading Strategies: Percentage Distribution (2021-2025)
FIG 7 Key Strategic Move: (Product Launches and Product Expansions : 2021, Nov – 2025, Apr) Leading Players
FIG 8 Porter Five Forces Analysis - Artificial Intelligence In Cardiology Market
FIG 9 Value Chain Analysis of Artificial Intelligence In Cardiology Market
FIG 10 Key Customer Criteria - Artificial Intelligence In Cardiology Market
FIG 11 LAMEA Artificial Intelligence In Cardiology Market share by Component, 2024
FIG 12 LAMEA Artificial Intelligence In Cardiology Market share by Component, 2032
FIG 13 LAMEA Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
FIG 14 LAMEA Artificial Intelligence In Cardiology Market share by Application, 2024
FIG 15 LAMEA Artificial Intelligence In Cardiology Market share by Application, 2032
FIG 16 LAMEA Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
FIG 17 LAMEA Artificial Intelligence In Cardiology Market share by Medical Condition, 2024
FIG 18 LAMEA Artificial Intelligence In Cardiology Market share by Medical Condition, 2032
FIG 19 LAMEA Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
FIG 20 LAMEA Artificial Intelligence In Cardiology Market share by Country, 2024
FIG 21 LAMEA Artificial Intelligence In Cardiology Market share by Country, 2032
FIG 22 LAMEA Artificial Intelligence In Cardiology Market by Country, 2025 - 2032, USD Million
FIG 23 Recent strategies and developments: Ultromics Ltd.
FIG 24 Recent strategies and developments: Tempus AI, Inc.
FIG 25 SWOT Analysis: Tempus AI, Inc.
FIG 26 Recent strategies and developments: Koninklijke Philips N.V.
FIG 27 SWOT Analysis: Koninklijke Philips N.V.
FIG 28 Recent strategies and developments: Viz.ai, Inc.
FIG 29 SWOT Analysis: GE HealthCare Technologies, Inc.